Beta adrenérgicos en el asma [editorial]
Meza Morales, Aurora; Arreguín Osuna, Lizardo; Cerino Javier, Ruth; Navarrete Suárez, Francisco; Ortíz Aldana, Ignacio.
Alergia (Méx.)
; 43(1): 2-4, ene.-feb. 1996.
Artículo en Español | LILACS | ID: lil-180564
Documentos relacionados
Inhaled <i>ß</i>2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?
Clinical pharmacology of long-acting beta-receptor agonists.
Cold Flow Evaluation in Transdermal Drug Delivery Systems by Measuring the Width of the Oozed Adhesive.
Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.
Mechano-sensitivity of ß2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonists.
Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
A non-parametric method to analyse time-course of effect in the absence of pharmacokinetic data: application to inhaled bronchodilators.
Inhaled beta agonists.
Clenbuterol Hydrochloride.
Enantioselective disposition of clenbuterol in rats.